A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects with Chronic Kidney Disease and Metabolic Acidosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2018
At a glance
- Drugs TRC 101 (Primary)
- Indications Acidosis; Kidney disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Tricida
- 14 Feb 2018 Planned primary completion date changed from 1 Apr 2018 to 1 May 2018.
- 14 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Dec 2017 Planned End Date changed from 21 Jun 2018 to 1 May 2018.